PharVision Advisers’s CDW CDW Stock Holding History

PharVision Advisers’s Portfolio CDW Stock Details CDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,159	Closed	-$202K	–	303
2024 Q4	$202K	Buy	+1,159	New	+$225K	0.17%	307

Other funds holding CDW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's CDW Position: Q1 2025 in Review

PharVision Advisers sold out of CDW (CDW) in Q1 2025, closing a stake of 1,159 shares — an estimated $202K sold.

PharVision Advisers first reported a position in CDW in Q4 2024 and held it in 1 quarter. The position peaked at $202K in Q4 2024. 840 funds tracked by Wall St. Rank hold CDW as of Q1 2025.

PharVision Advisers reported no remaining CDW position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 1,159 CDW shares in Q1 2025, an estimated $202K.
PharVision Advisers first reported a position in CDW in Q4 2024 and held it in 1 quarter.
PharVision Advisers's CDW position peaked at $202K in Q4 2024.
840 funds tracked by Wall St. Rank held CDW as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.